Some consider trade shows to be a necessary evil — be seen or be gone. Others see them as a great tool in their marketing kit. They are a really a combination of both. As we re-enter a more customary world of MedTech tradeshows and events, it may be useful to look at why we attend them in the first place.

An interview with our partners Larry Barr, Göran Brorsson, and Chuck Weikel discussing the first half of 2021 in the MedTech M&A markets.

Panelists Laurence Barr, Founding Partner at Middle Branch Partners; David Anderson, Managing Director at Capital One Healthcare; Marie Lotto, Senior Director of M&A Integration at Hologic; and moderator Charles Weikel, Founding Partner at Middle Branch Partners had a great conversation about the state of MedTech M&A markets and finance during late-COVID. If you couldn't attend the webinar, or want to revisit portions of the conversation, you may now view the archived video on YouTube.

Middle Branch Partners and Capital One are pleased to present the first in a series of webinars on MedTech, banking, and the state of mergers and acquisitions in 2021 and beyond. Speakers include: Laurence Barr, Founding Partner at Middle Branch Partners; David Anderson, Managing Director at Capital One Healthcare; and Marie Lotto, Senior Director of M&A Integration at Hologic.